Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

TxDOT Opts Balfour Beatty JV Team As Bidder For Dallas Horseshoe Project

Balfour Beatty Plc (BBY.L) said it has been named as best value bidder, as part of a design-build joint venture with Fluor Corp., to undertake the upgrades and replacements of river crossings in Dallas, Texas. The Texas Department of Transportation's, or TxDOT, estimate for the design, construction, utilities and right of way for the project is around $798 million, or 502 million pounds.

The 'Dallas Horseshoe' project calls for the upgrade and replacement of the I-30 and I-35E bridges and construction of additional lanes as well as the previously designed Margaret McDermott bridges. TxDOT will utilise design-build project delivery to shorten the construction schedule and lower the overall cost. The design work will start in early 2013 and construction will be completed in 2017.

Click here to receive FREE breaking news email alerts for Balfour Beatty Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks moved sharply higher over the course of the trading day on Tuesday, extending the recovery from the sell-off seen in recent weeks. The Nasdaq and the S&P 500 closed higher for the fourth consecutive session but remain well off their mid-September highs. Despite indications that the spread of Ebola inside the U.S. has been contained, the results of a new Gallup poll show the deadly disease had made its debut on a list of the top 10 most important problems facing the country. In another hotly contested Senate race, the results of a new Suffolk University/Boston Herald poll show incumbent Sen. Jeanne Shaheen, D-N.H., clinging to a narrow lead over Republican challenger Scott Brown.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.